Coagulase-negative staphylococci emerging during teicoplanin therapy and the determination of their sensitivity.
Jones
R N
RN
D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003030:Coagulase / Q000378:metabolism*; D004352:Drug Resistance, Microbial; D006020:Glycopeptides / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D013210:Staphylococcus / Q000187:drug effects / Q000201:enzymology*; D017334:Teicoplanin
D000900:Anti-Bacterial Agents; D003030:Coagulase; D006020:Glycopeptides; D017334:Teicoplanin